Day: April 4, 2025

Explore all our news . .

Recent Posts

Bitget Secures El Salvador Digital Asset Service Provider (DASP) License After BSP Approval

Bitget Secures El Salvador Digital Asset Service Provider (DASP) License After BSP Approval VICTORIA, Seychelles, April 04, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has obtained the Digital Asset Service Provider (DASP) license from El Salvador’s National Commission of Digital Assets (CNAD), expanding its regulatory

Bitget Secures El Salvador Digital Asset Service Provider (DASP) License After BSP Approval

Bitget Secures El Salvador Digital Asset Service Provider (DASP) License After BSP Approval VICTORIA, Seychelles, April 04, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has obtained the Digital Asset Service Provider (DASP) license from El Salvador’s National Commission of Digital Assets (CNAD), expanding its regulatory

1000 Miglia 2025, Official List of Accepted Cars

1000 Miglia 2024 BRESCIA, Italy, April 04, 2025 (GLOBE NEWSWIRE) — The wait is over: the list of cars that will participate in the 1000 Miglia 2025 has been drawn up by the Selection Committee that, year after year, has the task of choosing the cars that will take part

NMRA FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action First Filed by the Firm – NMRA

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neumora Therapeutics, Inc. (NASDAQ: NMRA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Neumora’s September 2023

NMRA FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action First Filed by the Firm – NMRA

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neumora Therapeutics, Inc. (NASDAQ: NMRA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Neumora’s September 2023